BlackRock Institutional Trust Company, N.A. - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 93 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q4 2016$3,623,000
+5.2%
899,0920.0%0.00%0.0%
Q3 2016$3,444,000
-10.6%
899,092
+0.3%
0.00%0.0%
Q2 2016$3,854,000
-9.6%
896,369
-2.6%
0.00%0.0%
Q1 2016$4,261,000
-53.7%
920,408
+0.4%
0.00%
-50.0%
Q4 2015$9,197,000
+38.7%
916,927
+3.1%
0.00%
+100.0%
Q3 2015$6,632,000
-81.6%
888,999
+16.7%
0.00%
-83.3%
Q2 2015$36,141,000
+47.5%
761,828
+13.9%
0.01%
+50.0%
Q1 2015$24,504,000
+44.3%
668,779
+56.4%
0.00%
+33.3%
Q4 2014$16,984,000
+303.5%
427,711
+102.7%
0.00%
+200.0%
Q3 2014$4,209,000
+10.4%
210,959
-25.3%
0.00%0.0%
Q2 2014$3,811,000
-11.8%
282,508
-28.8%
0.00%0.0%
Q1 2014$4,320,000
+14.1%
396,654
+41.7%
0.00%0.0%
Q4 2013$3,785,000
+29.3%
279,987
+8.8%
0.00%0.0%
Q3 2013$2,927,000
+86.0%
257,227
+14.9%
0.00%
Q2 2013$1,574,000223,9640.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q4 2016
NameSharesValueWeighting ↓
Opaleye Management Inc. 330,000$2,353,0000.98%
EcoR1 Capital, LLC 633,400$4,516,0000.80%
DLD Asset Management, LP 570,000$4,059,0000.53%
Rhenman & Partners Asset Management AB 300,000$2,139,0000.31%
Eventide Asset Management 600,000$4,278,0000.27%
Tekla Capital Management LLC 1,004,322$7,161,0000.26%
Rock Springs Capital Management LP 698,000$4,977,0000.25%
DLD Asset Management, LP 230,000$1,640,0000.21%
Worth Venture Partners, LLC 29,325$209,0000.18%
Crestline Management, LP 161,403$1,151,0000.15%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders